ClinicalTrials.Veeva

Menu
P

Pediatric Neurology and Epilepsy Specialists | Winter Park Office

Research site

Site insights

Top conditions

Top treatments

EPX-100
LY573144
Lasmiditan
Clemizole Hydrochloride
Ecopipam
Ubrogepant
Radiprodil
Soticlestat
Atogepant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Denise Hubert

Verified by this site

Active trials

10 of 10 total trials

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of m...

Enrolling
Migraine
Drug: Lasmiditan
Locations recently updated

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochl...

Enrolling
Dravet Syndrome
Drug: Placebo
Drug: Clemizole HCl

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks an...

Enrolling
Migraine
Drug: Placebo
Drug: Lasmiditan

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompa...

Enrolling
Chronic Migraine
Drug: Atogepant
Drug: Placebo for Atogepant

The main aim is to assess the long-term safety and tolerability of soticlestat when used along with other anti-seizure treatment.Participants will re...

Active, not recruiting
Dravet Syndrome (DS)
Epilepsy
Drug: Soticlestat

The primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to \[...

Active, not recruiting
Tourette Syndrome
Drug: Ecopipam

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX...

Enrolling
Lennox Gastaut Syndrome
Drug: Clemizole HCl
Drug: Placebo

Study RAD-GRIN-101 is a phase 1B trial to assess safety, tolerability, PK, and potential efficacy of radiprodil for the treatment of GRIN-related dis...

Active, not recruiting
GRIN-related Disorders
Drug: Radiprodil

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Invitation-only
Migraine
Drug: Ubrogepant
Locations recently updated

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Enrolling
Migraine
Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant

Trial sponsors

AbbVie logo
E
Lilly logo
E
G
Takeda logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems